ROYALTY PHARMA PLC (RPRX)
Royalty Pharma Plc engages in the provision of drug development services. It operates as a funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio includes royalties, including AbbVie and J&Ja€ s Imbruvica, Astellas and Pfizer
CS Hotline: +852 3018 4526
Trading days: 24 hours | Non-trading days: 9:00-18:00
